Pay in 4 interest-free payments of $6.96 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
Group peptides with similar temperature needs together
A 2015 study by Huang and colleagues in Drug Design, Development and Therapy used a rat alkali-burn model (n=10 per group) and HUVECs treated with BPC-157 at 200800 ng/mL, reporting accelerated wound closure with enhanced granulation tissue, reepithelialization, and dermal remodeling by day 18, alongside increased endothelial migration and vascular tube formation in vitro via ERK1/2 phosphorylation though the abstract does not report numeric % wound closure or p-values
10.1016/j.jdiacomp.2016.02.003 213 TbaraL
The regulatory profile is unambiguous: BPC-157 is not registered as a drug and since 2022 has been on the WADA list in category S0
Drasar PB, Khripach VA
US$ 26.80
US$ 28.04
US$ 20.73
US$ 26.91
US$ 29.29
